Cleavage at Arg1018 is not required for factor V activation

被引：0
|
作者：
Na, M. [1 ]
Wiencek, J. R. [1 ]
Hirbawi, J. [2 ]
Kalafatis, M. [1 ]
机构：
[1] Cleveland State Univ, Cleveland, OH 44115 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：472 / 472
页数：1
相关论文
共 50 条
  • [21] Anthrax Lethal Factor Cleavage of Nlrp1 Is Required for Activation of the Inflammasome
    Levinsohn, Jonathan L.
    Newman, Zachary L.
    Hellmich, Kristina A.
    Fattah, Rasem
    Getz, Matthew A.
    Liu, Shihui
    Sastalla, Inka
    Leppla, Stephen H.
    Moayeri, Mahtab
    PLOS PATHOGENS, 2012, 8 (03)
  • [22] Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein C
    Barhoover, Melissa A.
    Kalafatis, Michael
    BLOOD COAGULATION & FIBRINOLYSIS, 2011, 22 (04) : 317 - 324
  • [23] Proteolysis of factor V by cathepsin G indicates that cleavage at Arg(1545) optimizes factor Va cofactor activity in prothrombinase
    Camire, RM
    Kalafatis, M
    Tracy, PB
    THROMBOSIS AND HAEMOSTASIS, 1997, : OC244 - OC244
  • [24] Cleavage at arginine 306 is not required for inactivation of factor V by activated protein C (APC)
    Wei, CJ
    QuinnAllen, MA
    Kane, WH
    BLOOD, 1995, 86 (10) : 2446 - 2446
  • [25] HUMAN FACTOR-XA CLEAVAGE AND ACTIVATION OF PURIFIED PLASMA FACTOR-V AND PLATELET-RELEASED FACTOR-V
    MONKOVIC, DD
    TRACY, PB
    ARTERIOSCLEROSIS, 1988, 8 (05): : A707 - A707
  • [26] CLEAVAGE OF FACTOR-IX AT ARG 180-VAL 181 IS REQUIRED AND SUFFICIENT FOR OPTIMAL INTERACTION WITH FACTOR-VIIIA IN THE TENASE COMPLEX
    BENTAL, O
    PORTER, TI
    FURIE, B
    FURIE, BC
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 958 - 958
  • [27] The C-terminus of tissue factor pathway inhibitor-a inhibits factor V activation by protecting the Arg1545 cleavage site (vol 15, pg 140, 2017)
    van Doorn, P.
    Rosing, J.
    Wielders, S. J.
    Hackeng, T. M.
    Castoldi, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (07) : 1195 - 1195
  • [28] The prevalence of factor V Arg306→Thr (factor V Cambridge) and factor V Arg306→Gly mutations in different human populations
    Franco, RF
    Elion, J
    Tavella, MH
    Santos, SEB
    Zago, MA
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (02) : 312 - 313
  • [29] Factor Va cleavage and inactivation by activated protein C: The role of cleavage at Arg679.
    Orban, T
    Gogonea, V
    Kalafatis, M
    BLOOD, 2003, 102 (11) : 544A - 544A
  • [30] MOLECULAR DEFECT IN FACTOR-IXHILO, A HEMOPHILIA BM VARIANT ARG -] GLN AT THE CARBOXYTERMINAL CLEAVAGE SITE OF THE ACTIVATION PEPTIDE
    HUANG, MN
    KASPER, CK
    ROBERTS, HR
    STAFFORD, DW
    HIGH, KA
    BLOOD, 1989, 73 (03) : 718 - 721
12345